A dosimetric analysis of dose escalation using two intensity-modulated radiation therapy techniques in locally advanced pancreatic carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 65, Issue 1, 2006, Pages 274-283

  Brown, Michael W ^a   Ning, Holly ^a   Arora, Barbara ^a   Albert, Paul S ^a   Poggi, Matthew ^b   Camphausen, Kevin ^a   Citrin, Deborah ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Dose escalation; Intensity modulated radiation therapy (IMRT); Pancreatic cancer

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DOSIMETRY; DRUG DOSAGE; RADIOTHERAPY; THREE DIMENSIONAL; TISSUE;

DOSE ESCALATION; INTENSITY-MODULATED RADIATION THERAPY (IMRT); PANCREATIC CANCER; THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY (3D-CRT);

TUMORS;

ADVANCED CANCER; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; KIDNEY; LIVER; PANCREAS CARCINOMA; PRIORITY JOURNAL; RADIATION DEPTH DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; SMALL INTESTINE; SPINAL CORD; TARGET ORGAN; THREE DIMENSIONAL IMAGING; TISSUE DISTRIBUTION; TREATMENT PLANNING;

CARCINOMA; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEASIBILITY STUDIES; HUMANS; INTESTINE, SMALL; KIDNEY; LIVER; MAXIMUM TOLERATED DOSE; PANCREATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; SPINAL CORD;

EID: 33645964938     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.01.003     Document Type: Article

References (39)

1. Landis S.H., Murray T., Bolden S., et al. Cancer statistics 1998. Cancer 48 (1998) 6-29
2. Cancer facts and figures 2003. The American Cancer Society (2003)
3. Morohoshi T., Held G., and Kloppel G. Exocrine pancreatic tumors and their histological classification. A study based on 167 autopsy and 97 surgical cases. Histopathology 7 (1996) 645-661
4. Howard J.M., and Jordan Jr. G.L. Cancer of the pancreas. Curr Probl Cancer 2 (1977) 5-52
5. Brooks J. Cancer of the pancreas. In: Brooks J.R. (Ed). Surgery of the pancreas (1983), WB Saunders, Philadelphia 263
6. Rosenberg J.M., Welch J.P., and Macaulay W.P. Cancer of the head of the pancreas. An institutional review with emphasis on surgical therapy. J Surg Oncol 28 (1985) 217-221
7. Connolly M.M., Dawson P.J., Michelassi F., et al. Survival in 1001 patients with carcinoma of the pancreas. Ann Surg 206 (1987) 366-373
8. Singh S.M., Longmire Jr. W.P., and Reber H.A. Surgical palliation for pancreatic cancer. The UCLA experience. Ann Surg 212 (1990) 132-139
9. Funovics J.N., Karner J., Pratschner T., et al. Current trends in the management of carcinoma of the pancreatic head. Hepatogastroenterology 36 (1989) 450-455
10. Rich R. Radiation therapy for pancreatic cancer. In: Reber H. (Ed). Pancreatic cancer (1998), Humana Press, Totowa, NJ 281-294
11. Rich T.A., and Evans D.B. Preoperative combined modality therapy for pancreatic cancer. World J Surg 19 (1995) 264-269
12. Griffin J.F., Smalley S.R., Jewell W., et al. Patterns of failure after curative resection of pancreatic carcinoma. Cancer 66 (1990) 56-61
13. Moertel C.G., Frytak S., Hahn R.G., et al., The Gastrointestinal Tumor Study Group. Therapy of locally unresectable pancreatic carcinoma. A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. Cancer 48 (1981) 1705-1710
14. Roldan G.E., Gunderson L.L., Nagorney D.M., et al. External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer. Cancer 61 (1988) 1110-1116
15. Gunderson L.L., Martin J.K., Kvols L.K., et al. Intraoperative and external beam irradiation +/- 5-FU for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 13 (1987) 319-329
16. Mohiuddin M., Regine W.F., Stevens J., et al. Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas. J Clin Oncol 13 (1995) 2764-2768
17. Garton G.R., Gunderson L.L., Nagorney D.M., et al. High-dose preoperative external beam and intraoperative irradiation for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 27 (1993) 1153-1157
18. Shipley W.U., Tepper J.E., Warshaw A.L., et al. Intraoperative radiation therapy for patients with pancreatic carcinoma. World J Surg 8 (1984) 929-934
19. Shipley W.U., Nardi G.L., Cohen A.M., et al. Iodine-125 implant and external beam irradiation in patients with localized pancreatic carcinoma. A comparative study to surgical resection. Cancer 45 (1980) 709-714
20. Mohiuddin M., Cantor R.J., Biermann W., et al. Combined modality treatment of localized unresectable adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 14 (1988) 79-84
21. Landry J.C., Yang G.Y., Ting J.Y., et al. Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA). Employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicity. Med Dosim 27 (2002) 121-129
22. Ben-Josef E., Shields A.F., Vaishampayan U., et al. Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer. Int J Radiat Oncol Biol Phys 59 (2004) 454-459
23. Higgins P.D., Sohn J.W., Fine R.M., et al. Three-dimensional conformal pancreas treatment. comparison of four- to six-field techniques. Int J Radiat Oncol Biol Phys 31 (1995) 605-609
24. Li X.A., Wang J.Z., Jursinic P.A., et al. Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer. Int J Radiat Oncol Biol Phys 61 (2005) 1251-1257
25. Guerrero M., Li X.A., Ma L., et al. Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer. Radiobiological and dosimetric considerations. Int J Radiat Oncol Biol Phys 62 (2005) 933-939
26. Dogan N., King S., Emami B., et al. Assessment of different IMRT boost delivery methods on target coverage and normal-tissue sparing. Int J Radiat Oncol Biol Phys 57 (2003) 1480-1491
27. Guerrero M., Li X.A., Earl M.A., et al. Simultaneous integrated boost for breast cancer using IMRT. A radiobiological and treatment planning study. Int J Radiat Oncol Biol Phys 59 (2004) 1513-1522
28. Wu Q., Mohan R., Morris M., et al. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas. I. Dosimetric results. Int J Radiat Oncol Biol Phys 56 (2003) 573-585
29. Fu W.H., Wang L.H., Zhou Z.M., et al. Comparison of conformal and intensity-modulated techniques for simultaneous integrated boost radiotherapy of upper esophageal carcinoma. World J Gastroenterol 10 (2004) 1098-1102
30. Pinheiro J.C., and Bates D.M. Mixed-effects models in S and S-plus (2000), Springer, New York
31. Allen A.M., Zalupski M.M., Robertson J.M., et al. Adjuvant therapy in pancreatic cancer. Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine. Int J Radiat Oncol Biol Phys 59 (2004) 1461-1467
32. Morganti A.G., Valentini V., Macchia G., et al. 5-fluorouracil-based chemoradiation in unresectable pancreatic carcinoma. Phase I-II dose-escalation study. Int J Radiat Oncol Biol Phys 59 (2004) 1454-1460
33. Eisbruch A., Foote R.L., O'Sullivan B., et al. Intensity-modulated radiation therapy for head and neck cancer. Emphasis on the selection and delineation of the targets. Semin Radiat Oncol 12 (2002) 238-249
34. Zelefsky M.F., Fuks Z., and Leibel S.A. Intensity-modulated radiation therapy for prostate cancer. Semin Radat Oncol 12 (2002) 229-237
35. D'Souza W.D., Ahamad A.A., Iyer R.B., et al. Feasibility of dose escalation using intensity-modulated radiotherapy in posthysterectomy cervical carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 1062-1070
36. Gierga D.P., Chen G.T., Kung J.H., et al. Quantification of respiration-induced abdominal tumor motion and its impact on IMRT dose distributions. Int J Radiat Oncol Biol Phys 58 (2004) 1584-1595
37. Ozhasoglu C., and Murphy M. Issues in respiratory motion compensation during external-beam radiation therapy. Int J Radiat Oncol Biol Phys 52 (2002) 1389-1399
38. Dehnad H., Nederveen A.J., van der Heide U.A., et al. Clinical feasibility study for the use of implanted gold seeds as reliable positioning markers during megavoltage irradiation. Radiother Oncol 67 (2003) 295-302
39. McGinn C.J., Zalupski M.M., Shureiqi I., et al. Phase I trial of radiation dose escalation with concurrent weekly full-dose Gemcitabine in patients with advanced pancreatic cancer. JCO 19 (2001) 4202-4208